NORMAN GITLIN

Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology ATLANTA, GA NPI 1669463543

General Payments — all program years on this page

$252,753.99

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 250
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $21,038.61 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $128,245.00120
2019 $50,369.3253
2020 $15,098.0618
2021 $11,925.0012
2022 $16,248.8816
2023 $9,829.1214
2024 $21,038.6117

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1067524384 Ipsen Bioscience Inc. $9,690.00 01/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1144167175 Madrigal Pharmaceuticals $144.17 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144167179 Madrigal Pharmaceuticals $3,173.00 09/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1144167183 Madrigal Pharmaceuticals $49.87 09/26/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1144167186 Madrigal Pharmaceuticals $460.95 09/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1144167190 Madrigal Pharmaceuticals $4,935.00 09/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1144167194 Madrigal Pharmaceuticals $254.00 09/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1144167198 Madrigal Pharmaceuticals $80.91 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144167201 Madrigal Pharmaceuticals $226.86 09/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1144167205 Madrigal Pharmaceuticals $186.86 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144167209 Madrigal Pharmaceuticals $77.39 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144167212 Madrigal Pharmaceuticals $94.62 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144167216 Madrigal Pharmaceuticals $207.27 09/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1144167220 Madrigal Pharmaceuticals $12.28 09/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1144167224 Madrigal Pharmaceuticals $1,410.00 12/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1153647024 Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.28 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154763043 ORPHALAN INC $17.15 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.